6,678 trials
Pain · Fever
Primary: Area Under the Curve (AUC) 0-4 Hours of a Single Dose of Intravenous Ibuprofen (IVIb) Administered Over 5-7 Minutes. — 75.74 mcg*hr/mL
Cigarette Smoking · Tobacco Smoking · Smoking, Tobacco
Primary: CO-verified Smoking Status at 26 Weeks — 16.3; 12.6 percentage of participants
Gingivitis
Primary: Whole Mouth Mean Bleeding Index (BI) at Week 3 — 0.14; 0.20 score on a scale — p=<0.0001
Cholera (Disorder)
Primary: Cohort 1 (12-17 Yrs) Primary Endpoint - Seroconversion of Serum Vibriocidal Antibody Against V. Cholerae — 99.4; 0 percentage of participants
Cardiac Diagnostic Procedure · Cardiac Interventional Procedure · Femoral Access Site Closure
Primary: Assessment of Venous Thrombosis — 0; 0 Participants
HIV · Contraception
Primary: Percent of HIV Target Immune Cells Within Female Genital Mucosa and Blood — 26.6; 22.8; 16.9; 22.4 percentage of HIV target immune cells
Chronic Fatigue Syndrome
Primary: EEG Slow Wave Activity During Sleep — 0.00002653; 0.00002257 uV^2/Hz
Neoplasms
Primary: Dose Intensity of Vemurafenib — 95.3; 92.9; 94.5 Percentage of Planned Dose
Gout
Primary: Percentage of Serum Uric Acid (sUA < 6 mg/dL) Responders During Month 6 — 78.6 percentage of participants
Knee Osteoarthritis
Primary: To Identify Imaging Markers for Characterizing the Biochemical Profiles in Synovial Fluid and Cartilage in Knee OA After HA Injection
Depression
Primary: Change in Total HDRS-17 Score From Baseline to Week 4 — -7.2; -9.9 score on a scale
Pain
Primary: Number of Participants Achieving Pulpal Anesthesia Success. — 44; 40 Participants — p=1.00
Schizophrenia
Primary: Time to First Hospitalization — 530.6; 613.7 days
HCV Coinfection · Liver Disease · HIV
Primary: Total Number of HCV-infected Hepatocytes Measured in Liver Tissue Obtained by Liver Biopsy at Day 0 (Pre-treatment) and at Day 7 of Antiviral Therapy — 45; 16; 290; 2…
Scabies · Households
Primary: Number of Participants With Clinical Cure — 20; 33 Participants